首页 | 本学科首页   官方微博 | 高级检索  
     


The predictive value of the exercise ECG for major adverse cardiac events in patients who presented with chest pain in the emergency department
Authors:Judith M. Poldervaart  A. Jacob Six  Barbra E. Backus  Hector W. L. de Beaufort  Maarten-Jan M. Cramer  Rolf F. Veldkamp  E. Gijs Mast  Eugène M. Buijs  Wouter J. Tietge  Björn E. Groenemeijer  Luc Cozijnsen  Alexander J. Wardeh  Hester M. den Ruiter  Pieter A. Doevendans
Affiliation:1. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands
4. Zuwe Hofpoort Hospital, Woerden, The Netherlands
2. Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands
3. Department of Emergency Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands
5. Medical Center Haaglanden, Leidschendam, The Netherlands
6. St. Antonius Hospital, Nieuwegein, The Netherlands
7. Tergooi Hospital, Hilversum, The Netherlands
8. Diaconessenhuis Hospital, Leiden, The Netherlands
9. Gelre Hospitals, Apeldoorn, The Netherlands
10. Medical Center Haaglanden, The Hague, The Netherlands
Abstract:

Background

To improve early diagnostic and therapeutic decision making, we designed the HEART score for chest pain patients in the emergency department (ED). HEART is an acronym of its components: History, ECG, Age, Risk factors and Troponin. Currently, many chest pain patients undergo exercise testing on the consecutive days after presentation. However, it may be questioned how much diagnostic value the exercise ECG adds when the HEART score is already known.

Methods

A subanalysis was performed of a multicenter prospective validation study of the HEART score, consisting of 248 patients who underwent exercise testing within 7 days after presentation in the ED. Outcome is the predictive value of exercise testing in terms of major adverse cardiac events (MACE) within 6 weeks after presentation.

Results

In low-risk patients (HEART score ≤3), 63.1 % were negative tests, 28.6 % non-conclusive and 8.3 % positive; the latter were all false positives. In the intermediate-risk group (HEART score 4–6), 30.9 % were negative tests, 60.3 % non-conclusive and 8.8 % positive, half of these positives were false positives. In the high-risk patients (HEART score ≥7), 14.3 % were negative tests, 57.1 % non-conclusive and 28.6 % positive, of which half were false positives.

Conclusion

In a chest pain population risk stratified with HEART, exercise testing has only a modest contribution to clinical decision making. 50 % of all tests are non-conclusive, with high rates of false positive tests in all three risk groups. In intermediate-risk patients, negative exercise tests may contribute to the exclusion of disease. Clinicians should rather go for sensitive tests, in particular in patients with low HEART scores.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号